Notably, these leukemias often present with activating NOTCH1 mutations, suggesting that enhanced NOTCH signaling and aberrant TAL1, LYL1, LMO1, and/or LMO2 expression are collaborative events in the multistep pathogenesis of T-ALL [1], [2]. The gene discussed is LYL1; the disease is acute lymphoblastic leukemia.